|
End-of-day quote
Ho Chi Minh S.E.
2026-11-02
|
5-day change | 1st Jan Change | ||
| 84,800.00 VND | -2.42% |
|
-3.53% | -17.11% |
Company Valuation: DHG Pharmaceutical
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 14,774,306 | 11,100,341 | 13,597,591 | 13,584,517 | 13,375,323 | 11,087,267 | - | - |
| Change | - | -24.87% | 22.5% | -0.1% | -1.54% | -17.11% | - | - |
| Enterprise Value (EV) 1 | 12,828,324 | 11,100,341 | 11,845,622 | 11,426,573 | 11,221,427 | 9,224,767 | 9,229,467 | 9,236,467 |
| Change | - | -13.47% | 6.71% | -3.54% | -1.8% | -17.79% | 0.05% | 0.08% |
| P/E | 19.8x | 11.6x | 13.4x | 18x | 15.4x | 11.9x | 11.3x | 10.6x |
| PBR | 3.9x | 2.59x | - | - | - | - | - | - |
| PEG | - | 0.4x | 2.1x | -0.7x | 1x | 1.73x | 1.91x | 1.61x |
| Capitalization / Revenue | 3.69x | 2.37x | 2.71x | 2.78x | 2.54x | 2.04x | 1.95x | 1.86x |
| EV / Revenue | 3.2x | 2.37x | 2.36x | 2.34x | 2.13x | 1.7x | 1.62x | 1.55x |
| EV / EBITDA | 13.6x | 9.59x | 10.4x | 10.5x | 10.2x | 7.99x | 7.39x | 6.91x |
| EV / EBIT | 14.5x | 9.98x | 11.2x | 12.4x | 11.4x | 8.8x | 8.12x | 7.57x |
| EV / FCF | 30x | 16.6x | -48.1x | 9.3x | 9.48x | 18.9x | 11.3x | 10.9x |
| FCF Yield | 3.34% | 6.01% | -2.08% | 10.8% | 10.5% | 5.29% | 8.82% | 9.17% |
| Dividend per Share 2 | 4,000 | - | - | 10,000 | 10,000 | 7,000 | 7,200 | 7,500 |
| Rate of return | 3.54% | - | - | 9.62% | 9.78% | 8.25% | 8.49% | 8.84% |
| EPS 2 | 5,720 | 7,318 | 7,786 | 5,763 | 6,644 | 7,100 | 7,521 | 8,016 |
| Distribution rate | 69.9% | - | - | 174% | 151% | 98.6% | 95.7% | 93.6% |
| Net sales 1 | 4,003,170 | 4,676,016 | 5,015,395 | 4,884,868 | 5,266,963 | 5,435,000 | 5,690,600 | 5,958,700 |
| EBITDA 1 | 944,647 | 1,157,079 | 1,140,985 | 1,089,971 | 1,105,507 | 1,155,200 | 1,248,900 | 1,335,900 |
| EBIT 1 | 884,537 | 1,112,058 | 1,053,025 | 920,276 | 986,499 | 1,047,900 | 1,137,100 | 1,219,600 |
| Net income 1 | 777,220 | 988,455 | 1,051,490 | 778,920 | 897,576 | 928,400 | 983,400 | 1,048,100 |
| Net Debt 1 | -1,945,982 | - | -1,751,969 | -2,157,944 | -2,153,896 | -1,862,500 | -1,857,800 | -1,850,800 |
| Reference price 2 | 113,000.00 | 84,900.00 | 104,000.00 | 103,900.00 | 102,300.00 | 84,800.00 | 84,800.00 | 84,800.00 |
| Nbr of stocks (in thousands) | 130,746 | 130,746 | 130,746 | 130,746 | 130,746 | 130,746 | - | - |
| Announcement Date | 1/20/22 | 1/19/23 | 1/19/24 | 1/20/25 | 1/20/26 | - | - | - |
1VND in Million2VND
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 12.24x | 1.75x | 8.22x | 8.06% | 440M | |
| 41.42x | 14.01x | 31.06x | 0.48% | 1,263B | |
| 39.99x | 6.71x | 18.89x | 1.95% | 658B | |
| 36.71x | 8.6x | 17.71x | 2.35% | 521B | |
| 21.74x | 5.27x | 13.12x | 2.48% | 391B | |
| 97.38x | 6.07x | 25.8x | 2.28% | 369B | |
| 23.19x | 5.95x | 14.36x | 2.69% | 307B | |
| 24.47x | 4.89x | 13.87x | 1.77% | 290B | |
| 29.55x | 7.53x | 13.48x | 2.16% | 252B | |
| -40.86x | 7.45x | 46.76x | 1.94% | 212B | |
| Average | 28.58x | 6.82x | 20.33x | 2.62% | 426.24B | |
| Weighted average by Cap. | 36.40x | 8.82x | 22.82x | 1.7% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- DHG Stock
- Valuation DHG Pharmaceutical
Select your edition
All financial news and data tailored to specific country editions
